GRI Bio, Inc. (GRI)
NASDAQ: GRI · Real-Time Price · USD
1.670
-0.100 (-5.65%)
At close: Aug 14, 2026, 4:00 PM EDT
1.697
+0.027 (1.59%)
After-hours: Aug 14, 2026, 7:53 PM EDT

GRI Bio Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
3272--
Market Cap Growth
-8.89%-66.25%326.73%---
Enterprise Value
-8-13-2--
Last Close Price
1.676.91394.3216674.51--
PB Ratio
0.360.421.846.70--
P/TBV Ratio
0.290.421.846.70--
Debt / Equity Ratio
0.010.010.030.05-0.41-0.74
Net Debt / Equity Ratio
-1.04-1.36-1.22-6.93-0.41-0.73
Net Debt / EBITDA Ratio
1.010.680.600.16-0.30-3.33
Net Debt / FCF Ratio
0.910.800.570.20-0.61-4.16
Quick Ratio
13.913.113.070.670.010.02
Current Ratio
14.213.253.431.090.160.02
Return on Equity (ROE)
-185.67%-238.17%-382.52%---
Return on Assets (ROA)
-88.82%-103.93%-118.39%-416.93%-465.68%-226.54%
Return on Capital Employed (ROCE)
-103.60%-198.90%-200.70%-4300.00%139.00%22.80%
Earnings Yield
-326.62%-478.65%-110.90%-751.78%--
FCF Yield
-410.44%-407.91%-116.36%-518.87%--
SEC Filings: 10-K · 10-Q